Health spending: a test for capitalism?

9 September 2007

The inexorable rise in health care spending around the world could prove a major test for capitalism, according to Kenneth Rogoff, a Harvard University economist and a former chief economist at the International Monetary Fund. He says the increase in incomes, the aging of the population and new technologies have enabled people to live longer and to improve their quality of life, but that this has meant growth in health spending more than 3.5% higher than the rate of revenue growth in the USA, for example, over several decades.

Health spend to reach 30% of GDP by 2030

Some economists suggest that this spending, which at present accounts for 16% of the US economy, will reach 30% of Gross Domestic Product by 2030. Other countries have reported similar trends. Prof Rogoff says the opening of the 21st century saw the end of all the ideologies that threatened capitalism, but what is happening in health care could change this situation because, in many societies, health is seen as a right.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight